Notice of Request for Public To Submit Comments and Attend Public Meeting, 33507 [E7-11680]

Download as PDF Federal Register / Vol. 72, No. 116 / Monday, June 18, 2007 / Notices Dated: June 7, 2007. James Scanlon, Deputy Assistant Secretary for Planning and Evaluation (OSDP), Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 07–2980 Filed 6–15–07; 8:45 am] BILLING CODE 4151–05–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers of Disease Control and Prevention [Docket Number NIOSH 105] Notice of Request for Public To Submit Comments and Attend Public Meeting National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. jlentini on PROD1PC65 with NOTICES AGENCY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces the following meeting and request for public comment on the following draft document: ‘‘NIOSH Hazardous Drugs List Update.’’ The documents can found at: https:// www.cdc.gov/niosh/topics/hazdrug/ 2007publicmeeting. Public Comment Period: Comments must be postmarked by September 20, 2007. Comments may be submitted electronically to niocindocket@cdc.gov or to Diane Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio 45226. Comments should reference the NIOSH Docket Number 105. Meeting Date and Time: August 28, 2007 9 a.m.–5 p.m. Place: Marriott Metro Center Hotel, 775 12th Street, NW., Washington, DC 20005. Purpose of Meeting: To discuss and obtain comments on the draft document, ‘‘NIOSH Hazardous Drugs List Update.’’ Special emphasis will be placed on discussion of the following: (1) The appropriateness and relevancy of the NIOSH definition of Hazardous Drugs; (2) the appropriateness and relevancy of the drugs that fit the NIOSH definition; and (3) the appropriateness and relevancy of the drugs that do not fit the NIOSH definition. Status: The forum will include scientists and representatives from various government agencies, industry, VerDate Aug<31>2005 18:19 Jun 15, 2007 Jkt 211001 labor, and other stakeholders, and is open to the public, limited only by the space available. Persons interested in providing comments need to notify Diane Miller by July 20, 2007. Ms. Miller can be reached by telephone at (513) 533–8450 or by e-mail at niocindocket@cdc.gov. Persons wanting to provide comments will be permitted up to 10 minutes, subject to available time. If additional time becomes available, presenters will be notified. Oral comments given at the meeting will be recorded and included in the docket. Written comments will also be accepted at the meeting. NIOSH will use this information to help assess and revise the definition and/or list of Hazardous Drugs. Contact for Technical Information: Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 4676 Columbia Pkwy. MS C–26, Cincinnati, OH 45226, Telephone 513–533–8132, e-mail hazardousdrugs@cdc.gov. Contact Person for Submitting Comments/Meeting Attendance: Diane Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio 45226, telephone (513) 533–8450. All material submitted to the Agency should reference docket number NIOSH 105. All information received in response to this notice will be available for public examination and copying at the NIOSH Docket Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226. Dated: June 11, 2007. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E7–11680 Filed 6–15–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Statement of Organization, Functions and Delegation of Authority Notice is hereby given that I have redelegated to the TANF Regional Program Managers the following authorities vested in me by the Director, Office of Family Assistance (OFA) in the memoranda dated April 17, 2007. (a) Authorities Delegated 1. The authority to respond to general inquiries about established state, territorial, and tribal programs, to explain existing program policies, and to suggest referrals to other government agencies and private organizations. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 33507 2. The authority to request information from state, territorial, and tribal grantees relative to program policies and operations. 3. The authority to deem state TANF plan amendments as complete. 4. The authority to approve or disapprove state requests, as permitted under section 45 CFR 205.56(d), to utilize alternative data-matching sources for the Income Eligibility Verification System (IEVS). 5. The authority to approve or disapprove state IEVS targeting plans, pursuant to section 45 CFR 205.56(a)(1). 6. The authority to issue letters to state and tribal TANF grantees acknowledging their success in achieving work participation rates for a fiscal year. 7. The authority to advise and notify state TANF grantees concerning their applications for caseload reduction credits. 8. The authority to request caseload and expenditure data from state TANF grantees in order to establish a Tribal Family Assistance Grant (TFAG). 9. The authority to approve, request changes, or defer action on ‘‘Letters of Intent’’ submitted by tribal applicants who wish to operate a TANF program. 10. The authority to develop TANF technical assistance plans and proposals for the expenditure of technical assistance funds. 11. The authority to request additional information and consult with states and tribes on modifications to TANF corrective compliance plans submitted in response to a penalty determination. 12. The authority to serve as Approving Officials for audit resolution for state and tribal TANF programs, and for tribal NEW programs and Adult Assistance programs that do not involve cost disallowances. 13. The authority to approve Adult Assistance program plans and plan amendments. 14. The authority to approve Federal Financial Participation (FFP) in payments for repairs to homes owned by recipients of assistance under the Adult Assistance programs. (b) Limitations 1. This delegation of authority shall be exercised under the Department’s existing policies on delegations and regulations. 2. The authority to respond to general inquiries relative to established state, territorial, and tribal programs or to inquire about specific grantee policies and operations requires prior consultation with and concurrence of the Director, Division of State TANF E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

[Federal Register Volume 72, Number 116 (Monday, June 18, 2007)]
[Notices]
[Page 33507]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11680]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers of Disease Control and Prevention

[Docket Number NIOSH 105]


Notice of Request for Public To Submit Comments and Attend Public 
Meeting

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

    The National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC) announces the 
following meeting and request for public comment on the following draft 
document: ``NIOSH Hazardous Drugs List Update.''
    The documents can found at: https://www.cdc.gov/niosh/topics/
hazdrug/2007publicmeeting.
    Public Comment Period: Comments must be postmarked by September 20, 
2007. Comments may be submitted electronically to niocindocket@cdc.gov 
or to Diane Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway, 
MS C-34, Cincinnati, Ohio 45226. Comments should reference the NIOSH 
Docket Number 105.
    Meeting Date and Time: August 28, 2007 9 a.m.-5 p.m.
    Place: Marriott Metro Center Hotel, 775 12th Street, NW., 
Washington, DC 20005.
    Purpose of Meeting: To discuss and obtain comments on the draft 
document, ``NIOSH Hazardous Drugs List Update.'' Special emphasis will 
be placed on discussion of the following:
    (1) The appropriateness and relevancy of the NIOSH definition of 
Hazardous Drugs;
    (2) the appropriateness and relevancy of the drugs that fit the 
NIOSH definition; and
    (3) the appropriateness and relevancy of the drugs that do not fit 
the NIOSH definition.
    Status: The forum will include scientists and representatives from 
various government agencies, industry, labor, and other stakeholders, 
and is open to the public, limited only by the space available. Persons 
interested in providing comments need to notify Diane Miller by July 
20, 2007. Ms. Miller can be reached by telephone at (513) 533-8450 or 
by e-mail at niocindocket@cdc.gov. Persons wanting to provide comments 
will be permitted up to 10 minutes, subject to available time. If 
additional time becomes available, presenters will be notified. Oral 
comments given at the meeting will be recorded and included in the 
docket. Written comments will also be accepted at the meeting. NIOSH 
will use this information to help assess and revise the definition and/
or list of Hazardous Drugs.
    Contact for Technical Information: Barbara MacKenzie, NIOSH, Robert 
A. Taft Laboratories, 4676 Columbia Pkwy. MS C-26, Cincinnati, OH 
45226, Telephone 513-533-8132, e-mail hazardousdrugs@cdc.gov.
    Contact Person for Submitting Comments/Meeting Attendance: Diane 
Miller, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C-34, 
Cincinnati, Ohio 45226, telephone (513) 533-8450. All material 
submitted to the Agency should reference docket number NIOSH 105.
    All information received in response to this notice will be 
available for public examination and copying at the NIOSH Docket 
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226.

    Dated: June 11, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E7-11680 Filed 6-15-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.